
5mg
❄️Lyophilized powder (not reconstituted)
Discount per Quantity
| Quantity | Discount | Price per Unit |
|---|---|---|
| 5 - 10 | 10% | €26.99 |
| 11 - 20 | 15% | €25.49 |
| 21+ | 20% | €23.99 |
Rigorous third-party testing
Every batch of our research chemicals and peptides undergoes independent third-party laboratory testing for purity and identity.
Total: €29.99
GHRP-6 is supplied as a catalogued research material in 5mg.
The literature identity maps GHRP-6 to the defined amidated hexapeptide. The catalogue name does not identify an acetate, TFA or other supplied form, so parent registry data remain conditional on batch confirmation [1–3].
| Property | Value |
|---|---|
| Name and synonyms | Growth Hormone Releasing Peptide 6, Examorelin, SKF-110679 |
| Material category | Growth Hormone Secretagogue |
| Sequence | H-His-DTrp-Ala-Trp-DPhe-Lys-NH2 |
| Molecular formula | C46H56N12O6 |
| Average molecular mass | 873.01 g/mol |
| CAS Registry Number | 87616-84-0 |
| PubChem CID | CID 9919153 |
| Structural features | Synthetic hexapeptide containing D-amino acids (D-Trp, D-Phe) and a C-terminal amide. It is an agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). |
| Appearance | White to off-white lyophilised powder |
| Solubility | Soluble in bacteriostatic or sterile water. |
| Physical form | Catalogue vial; exact salt/counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
Registry values apply only to the specific molecular entity, sequence, termini and material form. Batch records take precedence over family-level literature identifiers.
GHRP-6 is a first-generation synthetic met-enkephalin derivative that potently stimulates growth hormone release. It acts as a ghrelin mimetic, binding to the GHS-R1a receptor. May also increase prolactin, cortisol, and appetite.
GHRP-6 is catalogued in authoritative substance and receptor resources as a synthetic peptide ligand used in growth-hormone-secretagogue receptor and signalling research. This supports controlled analytical and mechanistic studies, not a human-use claim [1–3].
Receptor classification and endocrine-response observations do not establish long-term safety, efficacy, dosage, administration, or medicine authorization. They also do not verify the identity, purity or amount of this catalogue batch.
GHRP-6 is covered by current anti-doping restrictions [4].
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | Catalogue GHRP-6, provisionally mapped to the free amidated parent peptide | A defined GHRP-6 salt reference with specified counter-ion |
| Structural distinction | The catalogue label does not establish the salt or counter-ion | Salt identity and stoichiometry are explicitly defined |
| Analytical implication | Verify D stereochemistry, amidation, intact mass, counter-ion, purity and net content | Reference mass and registry values apply only to the matching defined form |
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
Laboratory preparation, analytical-method selection, risk assessment, personal protective equipment and waste disposal should follow the applicable SDS and the institution's approved procedures.
| Research-use notice | This material is supplied exclusively for laboratory research by qualified professionals and is not intended for human or veterinary use. Purchasers are responsible for compliance with applicable local requirements. |
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
Follow the exact label, batch CoA and SDS together with the institution's risk assessment. Use only storage and stability information linked to the exact material form and batch.